Open AccessEffects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial
Author(s) -
T. Scott Stroup,
Matthew Byerly,
Henry A. Nasrallah,
Neepa Ray,
Ahsan Y. Khan,
J. Steven Lamberti,
Ira D. Glick,
Richard M. Steinbook,
Joseph P. McEvoy,
Robert M. Hamer
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/bpkg-gc25
Subject(s) - aripiprazole , quetiapine , olanzapine , risperidone , randomized controlled trial , medicine , coronary heart disease , metabolic syndrome , cardiology , psychiatry , schizophrenia (object oriented programming) , obesity
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom